Your browser doesn't support javascript.
loading
YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis.
You, Qi; Yao, Yuan; Wu, Jinyu; Cheng, Congcong; Li, Yunxiu; Yuan, Haitao.
Affiliation
  • You Q; Department of Gynecology and Obstetrics, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, PR China. Electronic address: yqvicky2001@sina.com.
  • Yao Y; Department of Infection Monitor, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, PR China.
  • Wu J; Department of Gynecology and Obstetrics, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, PR China.
  • Cheng C; Department of Gynecology and Obstetrics, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, PR China.
  • Li Y; Department of Gynecology and Obstetrics, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, PR China.
  • Yuan H; Department of Gynecology and Obstetrics, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, PR China.
Biomed Pharmacother ; 129: 110339, 2020 Sep.
Article in En | MEDLINE | ID: mdl-32563147
ABSTRACT
Ovarian cancer endangers the life of women worldwide. Plenty of lncRNAs have been found modulating the progression of ovarian cancer. Meanwhile, lncRNA DSCR8 (Down syndrome critical region 8) has been reported as an oncogene in hepatocellular carcinoma. In this study, we aimed to search the function of DSCR8 in ovarian cancer. qRT-PCR analysis assessed the expression of DSCR8 in ovarian cancer cells. EdU assay and colony formation assay was used to test cell proliferation. Flow cytometry analysis and TUNEL assay were conducted to investigate cell apoptosis. Wound healing assay and transwell invasion assay assessed cell migration and invasion. DSCR8 was significantly up-regulated in ovarian cancer cells. Inhibited DSCR8 could suppress the progression of ovarian cancer. Also, YY1 could activate the expression of DSCR8 in ovarian cancer cells. Meanwhile, DSCR8/miR-3192-5p/YY1 axis was identified in ovarian cancer cells. MiR-3192-5p could function as tumor suppresser in ovarian cancer cells. Furthermore, DSCR8 and YY1 (Yin Yang 1) transcription factor could play the regulatory network in ovarian cancer cells. In a word, YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / MicroRNAs / YY1 Transcription Factor / RNA, Long Noncoding Type of study: Prognostic_studies Language: En Journal: Biomed Pharmacother Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / MicroRNAs / YY1 Transcription Factor / RNA, Long Noncoding Type of study: Prognostic_studies Language: En Journal: Biomed Pharmacother Year: 2020 Type: Article